Primary Renal Lymphoma on a 48 Year Old Woman

A 48-year-old female presented to our hospital with the following medical conditions: Systemic arterial hypertension in treatment. She denies any allergies or surgical history.

She reports a history of asthenia and adynamia for 3 months, accompanied by intermittent pain in the left flank. She denies hematuria, fever or weight loss. She underwent an enhanced CT examination at the local hospital, and a mass (10 x 9 cm in diameter) was noted in the left kidney.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Renal Lymphoma Neoplasms

Age range

48 year–48 year

Sex eligibility

Female

Study type

Observational

Primary location

Mexican Institute Of Social Health

Mérida, Yucatán, 92227, Mexico

About this study

She underwent radical nephrectomy and lymph node dissection. with the following surgical findings: (Figure 3) Kidney measuring 7 x 6 x 5 cm, with a tumor located in the upper pole of approximately 12 cm, with abundant newly formed vessels, loose and firm adhesions tumor-spleen and tail of pancreas, 1 artery, 1 vein, 1 ureter.

Postoperative pathology and inmunohistochemistry indicated DLBCL wich only localized in the kidney. Bone marrow biopsy and CT of the chest region dod not show any evidence of linmphoma invasion. According to the findings, she was diagnosed with PRL. After operation the patient received the R-CHOP regimen.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient with renal lymphoma

Exclusion criteria

Patient without renal lymphoma

Treatment and study plan

radical nephrectomy

Procedure

open radical nephrectomy and lymph node dissection.

Primary outcomes

Cure of the disease

Time frame: 5 days

Complete cancer resection

Sponsors and collaborators

Lead sponsor

Instituto Mexicano del Seguro Social

Other Gov

Registry information

Official study title

Primary Renal Lymphoma: a Case Report and Review of the Literature.

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2024
First posted: Jul 29, 2024
Registry last updated: Jul 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed